EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

EXPERT REV MOL DIAGN
影响因子:3.6
是否综述期刊:
是否预警:不在预警名单内
是否OA:
出版国家/地区:ENGLAND
出版社:Taylor and Francis Ltd.
发刊时间:2001
发刊频率:Bimonthly
收录数据库:SCIE/Scopus收录
ISSN:1473-7159

期刊介绍

Expert Review of Molecular Diagnostics (ISSN 1473-7159) publishes expert reviews of the latest advancements in the field of molecular diagnostics including the detection and monitoring of the molecular causes of disease that are being translated into groundbreaking diagnostic and prognostic technologies to be used in the clinical diagnostic setting.Each issue of Expert Review of Molecular Diagnostics contains leading reviews on current and emerging topics relating to molecular diagnostics, subject to a rigorous peer review process; editorials discussing contentious issues in the field; diagnostic profiles featuring independent, expert evaluations of diagnostic tests; meeting reports of recent molecular diagnostics conferences and key paper evaluations featuring assessments of significant, recently published articles from specialists in molecular diagnostic therapy.Expert Review of Molecular Diagnostics provides the forum for reporting the critical advances being made in this ever-expanding field, as well as the major challenges ahead in their clinical implementation. The journal delivers this information in concise, at-a-glance article formats: invaluable to a time-constrained community.
分子诊断学专家评审(ISSN 1473-7159)发表了分子诊断学领域最新进展的专家评论,包括疾病分子病因的检测和监测,这些疾病分子病因被转化为用于临床诊断环境的开创性诊断和预后技术。每一期《分子诊断学专家评论》都包含对当前和新出现的与分子诊断学相关的主题的主要评论,并经过严格的同行评审过程;讨论该领域有争议问题的社论;以诊断测试的独立专家评估为特征的诊断配置文件;最近分子诊断学会议的会议报告和重要论文评估,包括对分子诊断治疗专家最近发表的重要文章的评估。分子诊断学专家评论提供了一个论坛,用于报告在这个不断扩展的领域中取得的关键进展,以及在其临床实施中面临的主要挑战。该杂志以简明扼要的文章格式提供这些信息:对一个时间紧迫的社区来说是非常宝贵的。
年发文量 80
国人发稿量 23.27
国人发文占比 0.29%
自引率 -
平均录取率0
平均审稿周期 较慢,6-12周
版面费 -
偏重研究方向 医学-病理学
期刊官网 http://www.tandfonline.com/toc/iero20/current
投稿链接 https://mc.manuscriptcentral.com/ero

期刊高被引文献

Metabolomic insights into pathophysiological mechanisms and biomarker discovery in clear cell renal cell carcinoma
来源期刊:Expert Review of Molecular DiagnosticsDOI:10.1080/14737159.2019.1607729
Liquid biopsy tracking of lung tumor evolutions over time
来源期刊:Expert Review of Molecular DiagnosticsDOI:10.1080/14737159.2020.1680287
Emerging methodologies for pathogen identification in bloodstream infections: an update
来源期刊:Expert Review of Molecular DiagnosticsDOI:10.1080/14737159.2019.1568241
ClonoSEQ assay for the detection of lymphoid malignancies
来源期刊:Expert Review of Molecular DiagnosticsDOI:10.1080/14737159.2019.1627877
Clinical utility of emerging biomarkers in prostate cancer liquid biopsies
来源期刊:Expert Review of Molecular DiagnosticsDOI:10.1080/14737159.2019.1675515
Circulating exosomal miRNAs: clinical significance in human cancers
来源期刊:Expert Review of Molecular DiagnosticsDOI:10.1080/14737159.2019.1673732
Current and future molecular diagnostics of gastric cancer
来源期刊:Expert Review of Molecular DiagnosticsDOI:10.1080/14737159.2019.1660645
Circulating biomarkers predictive of tumor response to cancer immunotherapy
来源期刊:Expert Review of Molecular DiagnosticsDOI:10.1080/14737159.2019.1659728
Technical considerations for circulating tumor DNA detection in oncology
来源期刊:Expert Review of Molecular DiagnosticsDOI:10.1080/14737159.2019.1568873
The applications of metabolomics in the molecular diagnostics of cancer
来源期刊:Expert Review of Molecular DiagnosticsDOI:10.1080/14737159.2019.1656530
Molecular characterization and diagnostic criteria of renal cell carcinoma with emphasis on liquid biopsies
来源期刊:Expert Review of Molecular DiagnosticsDOI:10.1080/14737159.2019.1665510
Recent advances in the development and evaluation of molecular diagnostics for Ebola virus disease
来源期刊:Expert Review of Molecular DiagnosticsDOI:10.1080/14737159.2019.1595592
Should next-generation sequencing tests be performed on all cancer patients?
来源期刊:Expert Review of Molecular DiagnosticsDOI:10.1080/14737159.2019.1564043
Screening, prenatal diagnosis, and prenatal decision for sex chromosome aneuploidy
来源期刊:Expert Review of Molecular DiagnosticsDOI:10.1080/14737159.2019.1613154
Advanced multimodal diagnostic approaches for detection of lung cancer
来源期刊:Expert Review of Molecular DiagnosticsDOI:10.1080/14737159.2019.1607299
Profile of the SeptiCyte™ LAB gene expression assay to diagnose infection in critically ill patients
来源期刊:Expert Review of Molecular DiagnosticsDOI:10.1080/14737159.2019.1567333
Accuracy of genotyping for HPV16 and 18 to triage women with low-grade squamous intraepithelial lesions: a pooled analysis of VALGENT studies
来源期刊:Expert Review of Molecular DiagnosticsDOI:10.1080/14737159.2019.1613890
Is a diagnostic blood test for chronic fatigue syndrome on the horizon?
来源期刊:Expert Review of Molecular DiagnosticsDOI:10.1080/14737159.2020.1681976
Current and emerging bladder cancer biomarkers with an emphasis on urine biomarkers
来源期刊:Expert Review of Molecular DiagnosticsDOI:10.1080/14737159.2020.1699791
Advancing cancer diagnostics with artificial intelligence and spectroscopy: identifying chemical changes associated with breast cancer
来源期刊:Expert Review of Molecular DiagnosticsDOI:10.1080/14737159.2019.1659727
Emerging urine-based proteomic biomarkers as valuable tools in the management of chronic kidney disease
来源期刊:Expert Review of Molecular DiagnosticsDOI:10.1080/14737159.2019.1657406
Role of metabolomics-derived biomarkers to identify renal cell carcinoma: a comprehensive perspective of the past ten years and advancements
来源期刊:Expert Review of Molecular DiagnosticsDOI:10.1080/14737159.2020.1704259
Serum heart-type fatty acid-binding protein as a predictor for the development of sepsis-associated acute kidney injury
来源期刊:Expert Review of Molecular DiagnosticsDOI:10.1080/14737159.2019.1642750
Promoter methylation of galanin receptors as epigenetic biomarkers for head and neck squamous cell carcinomas
来源期刊:Expert Review of Molecular DiagnosticsDOI:10.1080/14737159.2019.1567334
How does carrier status for recessive disorders influence reproductive decisions? A systematic review of the literature
来源期刊:Expert Review of Molecular DiagnosticsDOI:10.1080/14737159.2020.1690456
Prognostic significance of gamma-glutamyl transferase in patients with metastatic non-small cell lung cancer
来源期刊:Expert Review of Molecular DiagnosticsDOI:10.1080/14737159.2019.1579644
Clinical implementation of molecular methods in detection of microorganisms from blood with a special focus on PCR electrospray ionization mass spectrometry
来源期刊:Expert Review of Molecular DiagnosticsDOI:10.1080/14737159.2019.1607728
Diagnostics in space: will zero gravity add weight to new advances?
来源期刊:Expert Review of Molecular DiagnosticsDOI:10.1080/14737159.2020.1699061
An update on the use and discovery of prognostic biomarkers in acute decompensated heart failure
来源期刊:Expert Review of Molecular DiagnosticsDOI:10.1080/14737159.2019.1671188
Recent advances in molecular biomarkers for patients with hepatocellular carcinoma
来源期刊:Expert Review of Molecular DiagnosticsDOI:10.1080/14737159.2019.1638254
Applications and efficiency of flow cytometry for leukemia diagnostics
来源期刊:Expert Review of Molecular DiagnosticsDOI:10.1080/14737159.2019.1691918
The importance of pre- and post-test counseling for prenatal cell-free DNA screening for common fetal aneuploidies
来源期刊:Expert Review of Molecular DiagnosticsDOI:10.1080/14737159.2019.1571912
Antibodies against aberrant glycans as cancer biomarkers
来源期刊:Expert Review of Molecular DiagnosticsDOI:10.1080/14737159.2020.1687295
The cellular prion protein and its derived fragments in human prion diseases and their role as potential biomarkers
来源期刊:Expert Review of Molecular DiagnosticsDOI:10.1080/14737159.2019.1667231
Detection, prediction, and prognosis: blood circulating microRNA as novel molecular markers of head and neck cancer patients
来源期刊:Expert Review of Molecular DiagnosticsDOI:10.1080/14737159.2020.1699062
Current and emerging trends in point-of-care urinalysis tests
来源期刊:Expert Review of Molecular DiagnosticsDOI:10.1080/14737159.2020.1699063
Advances in multiplex nucleic acid diagnostics for blood-borne pathogens: promises and pitfalls - an update
来源期刊:Expert Review of Molecular DiagnosticsDOI:10.1080/14737159.2019.1559055
Vitamin D-binding protein as a biomarker to confirm specific clinical diagnoses
来源期刊:Expert Review of Molecular DiagnosticsDOI:10.1080/14737159.2020.1699064
Profile of the BD HPV OnclarityTM assay
来源期刊:Expert Review of Molecular DiagnosticsDOI:10.1080/14737159.2019.1622415
Methylation biomarker development in the context of the EU regulations for clinical use of in-vitro diagnostic devices
来源期刊:Expert Review of Molecular DiagnosticsDOI:10.1080/14737159.2019.1618188
POM121 overexpression is related to a poor prognosis in colorectal cancer
来源期刊:Expert Review of Molecular DiagnosticsDOI:10.1080/14737159.2020.1707670
How can biomarkers assist the prognosis of urologic malignancies?
来源期刊:Expert Review of Molecular DiagnosticsDOI:10.1080/14737159.2019.1665506
Advances in technologies for cervical cancer detection in low-resource settings
来源期刊:Expert Review of Molecular DiagnosticsDOI:10.1080/14737159.2019.1648213
Trends in biomarker discoveries for the early detection and risk stratification of pancreatic cancer using omics studies
来源期刊:Expert Review of Molecular DiagnosticsDOI:10.1080/14737159.2019.1643718
Fragile X molecular investigation and genetic counseling of intellectual disability/developmental delay patients in an Indian scenario
来源期刊:Expert Review of Molecular DiagnosticsDOI:10.1080/14737159.2019.1622416
Brief molecular diagnostic criteria for human cytomegalovirus infection/disease
来源期刊:Expert Review of Molecular DiagnosticsDOI:10.1080/14737159.2019.1657010
ID CORE XT as a tool for molecular red blood cell typing
来源期刊:Expert Review of Molecular DiagnosticsDOI:10.1080/14737159.2019.1656529
Measurement of blood activation markers applied to the early diagnosis of cardiovascular alterations
来源期刊:Expert Review of Molecular DiagnosticsDOI:10.1080/14737159.2020.1704258
Soluble CD163 is a potential biomarker in systemic sclerosis
来源期刊:Expert Review of Molecular DiagnosticsDOI:10.1080/14737159.2019.1571911
High serum caspase-3 levels in hepatocellular carcinoma prior to liver transplantation and high mortality risk during the first year after liver transplantation
来源期刊:Expert Review of Molecular DiagnosticsDOI:10.1080/14737159.2019.1619549

质量指标占比

研究类文章占比 OA被引用占比 撤稿占比 出版后修正文章占比
35.00%15.63%-2.33%

相关指数

影响因子
影响因子
年发文量
自引率
Cite Score

预警情况

查看说明
时间 预警情况
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
*来源:中科院《 国际期刊预警名单》

JCR分区

WOS分区等级:Q1区
版本 按学科 分区
WOS期刊SCI分区
WOS期刊SCI分区
WOS期刊SCI分区是指SCI官方(Web of Science)为每个学科内的期刊按照IF数值排 序,将期刊按照四等分的方法划分的Q1-Q4等级,Q1代表质量最高,即常说的1区期刊。
(2024-2025年最新版)
PATHOLOGY
Q1

中科院分区

查看说明
版本 大类学科 小类学科 Top期刊 综述期刊
2025年3月最新升级版
医学3区
PATHOLOGY 病理学
3区
2023年12月升级版
医学3区
PATHOLOGY 病理学
3区
2022年12月旧的升级版
医学3区
PATHOLOGY 病理学
3区